InvestSMART
  1. Home
  2. Research & Advice
  3. Research Tools
  4. Shares
  5. Global X S&P Biotech ETF (CURE)

Global X S&P Biotech ETF (ASX: CURE) - Share Price and Research

- Current share price for CURE : $49.940

Global X S&P Biotech ETF (CURE) is an Exchange Traded Fund - commonly known as an ETF. For more details about how ETFs work, feel free to check out our What is an ETF? overview. Global X S&P Biotech ETF (CURE, formerly ETFS S&P Biotech ETF) is an exchange traded fund that provides exposure to U.S. healthcare biotechnology companies. These companies are engaged in the research, development and manufacturing of products based on genetic analysis and genetic engineering.

CURE General Information +

ASX Code CURE
Website http://www.globalxetfs.com.au
Industry/Sector Asset Management & Custody Banks
Market Cap ($M) 37
CURE Share Price $49.940
Day High $0.000
Day Low $0.000
Last Close $49.940
CURE Share Price Movement - ( No change )
Prices as at 16:40, 24 Dec 2024
+Security prices are delayed by at least 20 minutes and are indicative only.

CURE Fund Information

Equity World Other
MSCI World Ex Australia NR AUD
starstar
Not Rated
Investment Fund
8 Nov 2018
$37.21 million (as at 13 Dec 2024)

CURE ETF performance (30 Nov 2024)

NOTE : returns for periods greater than 1 year are annualised
  1 Month % 3 Month % 6 Month % 1 Year % p.a. 2 Year % p.a. 3 Year % p.a. 5 Year % p.a. 10 Year % p.a.
Total return 3.19 2.3 14.1 33.83 10.37 -2.49 1.78 -
Growth return 3.19 2.3 14.1 33.83 10.37 -2.51 -2.23 -
Income return (Yield) 0 0 0 0 0 0.02 4.01 -

Market index (MSCI World Ex Australia NR AUD)
Total return 5.18 8.79 13.61 30.23 22.04 11.92 13.37 13.17

CURE Related Research

Global X S&P Biotech ETF (CURE) Upcoming Dividends & Yields

Distribution Type Dividend Franking Ex-dividend date Payment date Current Price+ Price 7D Avg Dividend Yield
HFResult 2.4¢ 0% 30 Jun 2022 15 Jul 2022 $49.940 $50.750 -
HFResult $6.26 0% 30 Jun 2021 15 Jul 2021 $49.940 $50.750 -
HFResult $6.76 0% 30 Jun 2020 15 Jul 2020 $49.940 $50.750 -

See all dividends from Global X S&P Biotech ETF (CURE) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

Global X S&P Biotech ETF (CURE) Recent ASX Announcements

Company Sector Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
Global X S&P Biotech ETF (CURE) Financials $37 Global X Units on Issue - November 2024 5 Dec 2024 9:12AM $51.970 $49.940 fallen by 3.91%
Global X S&P Biotech ETF (CURE) Financials $37 Global X Units on Issue - October 2024 4 Nov 2024 5:25PM $51.120 $49.940 fallen by 2.31%
Global X S&P Biotech ETF (CURE) Financials $37 Global X Units on Issue - September 2024 4 Oct 2024 5:02PM $48.110 $49.940 risen by 3.80%
Global X S&P Biotech ETF (CURE) Financials $37 Annual Financial Report 20 Sep 2024 2:52PM $51.150 $49.940 fallen by 2.37%
Global X S&P Biotech ETF (CURE) Financials $37 PDS dated 16 September 2024 16 Sep 2024 5:11PM $51.730 $49.940 fallen by 3.46%
Global X S&P Biotech ETF (CURE) Financials $37 Global X Units on Issue - August 2024 6 Sep 2024 5:17PM $49.700 $49.940 risen by 0.48%

CURE Financial Summary

Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2024A $4.07 $494.30 -32.70% 8.90 0.00 0.00% 0.0%
2023A $6.79 $734.30 -131.30% 5.80 0.00 0.00% 0.0%
2022A -$26.60 -$2,346.00 -987.90% 0.00 2.40 0.10% 0.0%

CURE Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2022 A 2023 A 2024 A 2022 A 2023 A 2024 A 2022 A 2023 A 2024 A
Global X S&P Biotech ETF (CURE) $37M -0.3269 0.0000 0.0000 10.1032 0.0000 0.0000 0.00% 0.00% 0.00%
HMC Capital (HMC) $4,206M 0.0191 0.0000 0.0000 48.8974 0.0000 0.0000 1.18% 0.00% 0.00%
Insignia Financial (IFL) $2,401M 0.6567 -0.2226 0.0203 7.5400 9.6993 9.5061 2.60% 2.23% 6.70%
Netwealth Group (NWL) $7,025M 0.2382 0.2487 0.2325 84.1642 67.4025 54.6875 0.98% 1.23% 1.49%
Pinnacle Investment Management Group (PNI) $5,190M 0.1667 0.1969 0.1911 50.3297 42.0492 35.3014 1.83% 2.14% 2.55%

CURE Market Comparison

Earnings P/E Ratio P/B Ratio P/E Growth
Company 0.00 10.10 1.05 0.00
Market 0.29 13.70 1.08 0.86
Sector 0.00 0.00 0.00 0.00

CURE Directors

Name Position Start Date
Mr Oliver Joseph Reynolds Non-Executive Director 11 Sep 2023
Mr Evan Metcalf Non-Executive Director 15 Jun 2022
Young Kim Non-Executive Director 15 Jun 2022
Mr Namki Kim Non-Executive Director 30 Jul 2024
Mr Emanual Damianakis Non-Executive Director 5 Aug 2024

Global X S&P Biotech ETF (CURE) Changes in Directors' Interest & Trades

There are no directors' trades from Global X S&P Biotech ETF (CURE). Please use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

CURE Calendar of Events

Date Event
19 September 2025 Report (Annual)

FAQs about Global X S&P Biotech ETF (CURE)

Global X S&P Biotech ETF's (CURE) current share price is $49.94. This constitutes a price movement of 1.60% when compared to the share price 7 days ago and is -8.05% below CURE's 12-month high of $54.31 per share. Prices are delayed by at least 20 minutes.

Relative to the previous close share price of $49.94, Global X S&P Biotech ETF's (CURE) current share price of $49.94 constitutes a movement of or 0%. Global X S&P Biotech ETF's (CURE) share price movement is -1.60% when compared to 7 days ago and is -8.05% below CURE's 52-week high of $54.31.

Global X S&P Biotech ETF's (CURE) 52-week high is $54.31 which was reached on 11 Nov 2024. Relative to this, CURE's current share price of $49.94 constitutes a -$4.37 or -8.05% drop since that high of $54.31 per CURE share.

Global X S&P Biotech ETF's (CURE) 52-week low is $42.72 which was reached on 26 Apr 2024. Relative to this, CURE's current share price of $49.94 constitutes a $7.22 or 16.90% gain since that low of $42.72 per CURE share.

Global X S&P Biotech ETF's (CURE) current market capitalisation is $37,155,959. Market capitalisation, sometimes referred to as "market cap", is the total value of a company's or ETF's issued shares or units owned by shareholders or unitholders. Market capitalisation is equal to the market price per share or unit multiplied by the number of shares or units outstanding.

Global X S&P Biotech ETF (CURE) last distribution or dividend was $0.02 per share and was paid on 15 Jul 2022. This last CURE distribution or dividend included 0% franking.

Upcoming ex-distribution date: 30 Jun 2022

Upcoming record date: 1 Jul 2022

Upcoming payment date: 15 Jul 2022

ETFs, such as Global X S&P Biotech ETF (CURE), pay distributions instead of dividends. The difference is that dividends are declared by companies from part of the profits made during any given year and the company’s management decide the amount of earnings retained verses how much to pay out to investors. An ETF, like Global X S&P Biotech ETF (CURE), must pay out all realised income. This is a combination of any dividends received plus capital gains realised from the buying and selling of underlying holdings within Global X S&P Biotech ETF (CURE).


A distribution has three key dates:

Ex-distribution date: Date the distribution value leaves the ETF. This will normally correspond with the ETF unit price dropping in value by the same amount as the distribution.

Record date: Date someone must be on the unit registry to receive the distribution.

Payment date date: Date the distribution is paid to the unit holder.

Global X S&P Biotech ETF (CURE) has a franking level of 0%. Franking represents the tax a company has already paid on any profit it distributes to shareholders as a dividend. Only Australian companies pay franking credits therefore you will not see franking on ETFs that invest internationally. For ETFs that are diversified across asset classes, you may see partial franking.

Global X S&P Biotech ETF (CURE) has a current dividend yield of 0% this year. Last year's dividend yield was 0%. The dividend yield for CURE is a ratio that tells you the percentage of Global X S&P Biotech ETF (CURE)'s share price that it pays out in dividends each year. The dividend yield is calculated by dividing the annual dividends by the current share price.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.